RecruitingPhase 4NCT06753500

Intraoperative Autonomic Blockade for Laparoscopic Cholecystectomy

Intraoperative Autonomic Blockade to Prevent Early Postoperative Pain After Laparoscopic Cholecystectomy: A Double-Blind, Randomized Controlled Trial


Sponsor

Universidad Simón Bolívar

Enrollment

60 participants

Start Date

Jan 15, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This study proposes infiltrating the hepatoduodenal ligament and the serosal reflection of the gallbladder cystic plate with a combination of Bupivacaine (a long-acting local anesthetic) and Dexamethasone (a corticosteroid). This technique aims to block the hepatic branches of the celiac plexus to improve visceral pain control and its associated clinical manifestations, reduce analgesic requirements, and lower readmission rates, thereby facilitating recovery.


Eligibility

Min Age: 18 Years

Inclusion Criteria1

  • Elective or emergency laparoscopic cholecystectomy for cholelithiasis with or without cholecystitis.

Exclusion Criteria4

  • Associated biliary pathologies (e.g., biliary pancreatitis, cholangitis).
  • Additional procedures, such as formal bile duct exploration. Conversion to an open approach
  • Anesthesia or Surgical complications that require intensive care unit
  • Allergies to local anesthetics

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREAutonomic neural blockade

Autonomic nerve block performed with: * Bupivacaine: 20 mL of 0.5%. * Dexamethasone: 8 mg.


Locations(2)

Clinica Portoazul

Barranquilla, Atlantivo, Colombia

clinica Iberoamerica

Barranquilla, Atlántico, Colombia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06753500


Related Trials